Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Sep;10(9):e80.
doi: 10.1016/S2213-2600(22)00271-5.

Interrupting methotrexate to improve immunity after COVID-19 booster vaccination: is it really worth it?

Anselm Jorda  1 , Markus Zeitlinger  2
Affiliations
Comment

Interrupting methotrexate to improve immunity after COVID-19 booster vaccination: is it really worth it?

Anselm Jorda et al. Lancet Respir Med. 2022 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

References

    1. Abhishek A, Boyton RJ, Peckham N, et al. Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial. Lancet Respir Med. 2022;10:840–850. - PMC - PubMed
    1. Feng S, Phillips DJ, White T, et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med. 2021;27:2032–2040. - PMC - PubMed
    1. Gilbert PB, Montefiori DC, McDermott AB, et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Science. 2022;375:43–50. - PMC - PubMed
    1. Chang MR, Ke H, Coherd CD, et al. Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by beta and omicron variants. EBioMedicine. 2022;80 - PMC - PubMed